Showing Results for
- Academic Journals (5,461)
Search Results
- 5,461
Academic Journals
- 5,461
-
From:Pharmaceutical Technology Europe (Vol. 25, Issue 5) Peer-ReviewedLyophilisation, or freeze drying, is an important manufacturing step widely used to increase the stability of pharmaceutical and biological products. Developed during the 1940s, lyophilisation produces a dry product...
-
From:Avicenna Journal of Medical Biotechnology (Vol. 5, Issue 1) Peer-ReviewedIran has taken significant steps in the fields of animal cloning, stem cell therapy and recombinant protein drugs in the past decade. The cloning of animals, stem cell therapies and transplantation by the Iranian stem...
-
From:Pharmaceutical Technology Europe (Vol. 25, Issue 8) Peer-ReviewedAs a drug type, peptides offer certain benefits, such as specificity and potency, but they also present challenges, such as poor stability and short half-life. Stapled peptides, small modified helical proteins, are an...
-
From:Journal of Commercial Biotechnology (Vol. 19, Issue 3) Peer-ReviewedThis paper examines the roles of culture in the principles of biomedical ethics. Drawing on examples from African, Navajo and Western cultures, the paper maintains that various elements of culture are indispensable to...
-
From:Nature Biotechnology (Vol. 32, Issue 2) Peer-ReviewedThomas C. Reynolds has been elected to the board of directors of Oxford BioTherapeutics (Oxford, UK and San Jose, CA, USA). Reynolds has over 20 years of biotech industry experience, most recently serving as chief...
-
From:Nature (Vol. 505, Issue 7486) Peer-ReviewedPanama has joined a handful of nations trying to combat dengue fever using genetically modified mosquitoes developed by Oxitec, a biotechnology firm in Oxford, UK (see go.nature. com/tht55x). The company announced on 28...
-
From:Nature (Vol. 463, Issue 7280) Peer-ReviewedGene company reboots: Two months after filing for bankruptcy, the 14-year-old genomics company deCODE Genetics, based in Reykjavik, has been resurrected as a newly financed private company. Research will be headed by...
-
From:Nature Biotechnology (Vol. 28, Issue 9) Peer-ReviewedInvida Group (Singapore) has announced that it has added three new members to its senior management team: Sumeet Sud has been named to the newly created role of chief marketing officer, and Girdhar Balwani and Thomas...
-
From:Pharmaceutical Technology Europe (Vol. 22, Issue 12) Peer-ReviewedBiotech has had a profound impact on the pharma industry by helping to develop new medicines that treat patients more effectively; however, despite its achievements, it hasn't made a significant difference to the number...
-
From:Nature (Vol. 457, Issue 7229) Peer-ReviewedTECHNOLOGY FEATURE: GLYCOBIOLOGY COMPANY PRODUCTS/ACTIVITY LOCATION Glycobiology companies Dextra Laboratories Monosaccharides, glycoconjugates Reading, UK and N-linked oligosaccharides GlycoFi Engineered yeast strains...
-
From:Pharmaceutical Technology Europe (Vol. 21, Issue 1) Peer-ReviewedA European initiative hopes to unite research, industrial and training resources in the biotech and medtech sectors by creating the 'Alps Bio Cluster' over an extended transalpine area. The partners involved in the...
-
From:Avicenna Journal of Medical Biotechnology (Vol. 1, Issue 2) Peer-ReviewedIn this study, an attempt has been made to expound the Iranian law of intellectual property in relation to biotechnology. The most important themes studied are patents, industrial designs and trade marks. The latest...
-
From:Nature Biotechnology (Vol. 26, Issue 11) Peer-ReviewedWith a population of 1.3 billion and a rapidly expanding economy, China has become a manufacturing powerhouse and one of the largest consumer product markets in the world. Its current drug market of $15 billion is...
-
From:Formulary (Vol. 43, Issue 8) Peer-Reviewed* Ustekinumab (Centocor) for the treatment of moderate-to-severe plaque psoriasis in adults...
-
From:Pharmaceutical Technology Europe (Vol. 20, Issue 8) Peer-ReviewedAustralia Australian self-Medication Industry Inc. Level 22, 141 Walker Street PO BOX 764 (2059) North Sydney NSW 2060 Tel. +61 29922 5111 Fax +61 29959 3693 info@asmi.com.au www.asmi.com.au...
-
From:Pharmaceutical Technology (Vol. 31, Issue 2) Peer-ReviewedBasel, Switzerland (Dec 5)--Lonza Group Ltd. (www.lonza.com) and Singapore's Bio*One Capital (www.biolcapital.com) have formed a joint venture, Lonza Biologics Tuas, to build a large-scale mammalian cell-culture...
-
From:Applied Clinical Trials (Vol. 16, Issue 4) Peer-ReviewedFive of six patients in a Phase Ib trial of Active Biotech's (Lund, Sweden) investigational treatment for prostate cancer, TASQ, exhibited a decrease in prostate specific antigen (PSA) velocity. Rising levels of PSA is...
-
From:Regenerative Medicine (Vol. 1, Issue 5)Author(s): Chris Mason [[dagger]] 1 , Mike Hoare 1 Here, we first examine whether lessons may be learned for autologous cell processing from other fields addressing personalized targets. We then summarize how...
-
From:The Scientist (Vol. 19, Issue 19) Peer-ReviewedThink of China, and what comes to mind? Cheap land, cheap labor and low manufacturing costs. One does not imagine that high-tech industries such as biotechnology and nanotechnology would be a priority for a government...
-
From:Pharmaceutical Technology Europe (Vol. 18, Issue 5) Peer-ReviewedThe British drug development company Inpharmatica has announced a collaboration with American firm Ingenuity Systems. The pair are to share their independently-developed drug discovery tools. Inpharmatica will bring its...